Does the progression-free interval after primary chemotherapy predict survival after salvage chemotherapy in advanced and recurrent endometrial cancer?: a Gynecologic Oncology Group ancillary data analysis.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples